SEARCH

SEARCH BY CITATION

References

  • 1
    Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257 63.
  • 2
    Garcia-Rodriguez LA & Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769 72.
  • 3
    Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075 8.
  • 4
    Carson JL, Strom BL, Soper KA, et al. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987; 147: 85 8.
  • 5
    Carson JL, Strom BL, Morse ML, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987; 147: 1054 9.
  • 6
    Kaufman DW, Kelly JP, Sheehan JE, et al. Non-steroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485 94.
  • 7
    Henry D, Dobson A, Turner C. Variability in the risk of major GI complications from non-aspirin non-steroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078 108.
  • 8
    Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462 4.
  • 9
    Savage RL, Moller PW, Ballantyne CL, et al. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arth Rheum 1993; 36: 84 90.
  • 10
    Henry D. Variability in risk of major upper gastrointestinal complications with individual NSAIDs. Importance of drug dose and half-life; results of meta analysis. In Side Effects of Anti-inflammatory Drugs IV. UK: Kluwer Publishers, 1997: 327–44.
  • 11
    Garcia Rodriguez AL. Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis. Semin Arthritis Rheum 1997; 26: 16 20.
  • 12
    Garcia Rodriguez LA. Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104(3A): 30S 34S.
  • 13
    Furey SA, Waksman JA, Dash BH. Nonprescription ibuprofen: side effect profile. Pharmacotherapy 1992; 12: 403 7.
  • 14
    DeArmond B, Francisco C, Lin JS, et al. Safety profile of over-the-counter naproxen sodium. Clin Ther 1995; 17(4): 587 601.
  • 15
    Bradley JD, Brandt KD, Katz BP, et al. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87 91.
  • 16
    Strom BL, Schinnar R, Bilker WB, et al. Gastrointestinal tract bleeding associated with naproxen sodium versus ibuprofen. Arch Intern Med 1997; 157; 2626 31.
  • 17
    Gallup Eighth Annual Study of Consumers’ Awareness and Usage of Non-Prescription Pain Relievers. A Monthly Tracking Study May 1992.
  • 18
    SmithKline Diagnostics, Inc. Hemoccult® Technical Brochure 4th edn. 1990.
  • 19
    Henry D, Lim LL-Y, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996; 312: 1563 6.
  • 20
    Alarcon-Segovia D. Long-term treatment of symptomatic osteoarthritis with benoxaprofen. Double-blind comparison with aspirin and ibuprofen. J Rheumatol 1980; Suppl. 6: 89 99.
  • 21
    Tyson VCH & Glynne A. A comparative study of benoxaprofen and ibuprofen in osteoarthritis in general practice. J Rheumatol 1980; Suppl. 6: 132 8.
  • 22
    Young GP & St. John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front Gastrointest Res 1991; 18: 135 6.